Sophie Grigolo | Immunology and Microbiology | Young Researcher Award

Mrs. Sophie Grigolo | Immunology and Microbiology | Young Researcher Award

University of Fribourg | Switzerland

Mrs. Sophie Grigolo is an emerging researcher specializing in cellular and molecular biology, with a strong focus on cancer research, particularly clear-cell renal-cell carcinoma (ccRCC). Her work encompasses extensive laboratory expertise in cell culture using human kidney cancer cell lines (A-498, ACHN, Caki-1, and Caki-2) and a range of analytical assays including BrdU Cell Proliferation, MTT, LDH, and Live-or-Dye™ Fixable Viability Staining. She is proficient in advanced molecular biology techniques such as polymerase chain reaction (PCR), agarose gel electrophoresis, western blotting, genotyping, flow cytometry, and immunohistochemistry (IHC), which she applies to elucidate cancer cell behavior and therapeutic responses. Her publications, including studies on immunotherapy in ccRCC and the role of IL-2 receptor expression in renal carcinoma cells, contribute to advancing understanding of tumor immunology and targeted therapies. Sophie has also shared her findings at prestigious scientific forums, including the International Student Congress of (bio)Medical Sciences and the Annual European Student Symposium on Anatomical Research, where her work has earned recognition for excellence. Through her research and technical acumen, she continues to contribute to the evolving field of cancer biology and the development of innovative therapeutic approaches.

Profile : Orcid

Featured Publications

Grigolo, S., Fellay, I., & Filgueira, L. (2025). IL-2 receptor expression in renal cell carcinoma cells: IL-2 influences cell survival and induces cell death. Current Issues in Molecular Biology, 47(10), 830.

Grigolo, S., & Filgueira, L. (2024). Immunotherapy of clear-cell renal-cell carcinoma. Cancers, 16, 2092.

Izeta Aganovic Musinovic | Immunology and Microbiology | Best Researcher Award

Prof. Izeta Aganovic Musinovic | Immunology and Microbiology | Best Researcher Award

University of Sarajevo | Bosnia and Herzegovina

Author Profile

Google Scholar

Early Academic Pursuits

Izeta Aganovic Musinovic embarked on her academic journey at the Medical School, University of Sarajevo, earning her Medical Doctor degree in 1994. She further delved into Genetics, completing a Master of Science thesis on chromosomal aberrations in populations exposed to ionizing radiation during wartime.

Professional Endeavors

Her career spanned across various roles at the Centers for Human Genetics and the Department of Immunology at the University of Sarajevo, evolving from an Associate to Senior Associate. She pursued a Residency Program in Immunology, culminating in a Doctor of Science in Immunology. Her trajectory included roles as a Senior Assistant Lecturer and Assistant Professor, contributing significantly to the Department of Immunology.

Contributions and Research Focus

Aganovic Musinovic's contributions notably revolved around immunobiological markers in assessing renal function injury in multiple myeloma patients. Her research journey spanned topics encompassing genetics, hematological disorders, and immunology, evident through her thesis work and subsequent teaching roles in Immunology, Hematology, and Nephrology.

Accolades and Recognition

Her academic achievements were evident through the completion of a Doctor of Science in Immunology and a Master's thesis in Genetics, affirming her commitment to advanced research and academia. The recognition of her contributions was reflected in her appointments as Associate and subsequently as Assistant and Associated Professor at the University of Sarajevo.

Impact and Influence

Aganovic Musinovic's influence was pronounced in the field of Immunology, particularly in advancing the understanding of immunobiological markers for renal function assessment in patients with multiple myeloma. Her teaching roles and extensive research endeavors have contributed to shaping the academic landscape in genetics, immunology, and related medical disciplines.

Legacy and Future Contributions

Her legacy lies in her comprehensive exploration of immunological markers and genetic factors impacting renal function in hematological disorders. Aganovic-Musinovic's commitment to academia, coupled with her research focus, lays the groundwork for future advancements in understanding renal function, genetics, and immunology within medical contexts. Her continued dedication is poised to shape the next generation of medical professionals and drive further breakthroughs in the field.

Notable Publications

Clinical management of patients with systemic lupus erythematosus (SLE) with different C1q-CIC and C3 concentrations 2010 (10)

The Impact of Rituximab Therapy on the Chromosomes of Patients with Rheumatoid Arthritis 2010 (5)

Evaluation of ENA-6 Profile by ELISA Immunoassay in Patients with Systemic Lupus Erythematodes 2012 (4)

Sex prediction by geometric morphometric analysis of the hard palate 2022 (2)

Effects of topically applied diclofenac and ketoprofen on Prostaglandin E2 and Stat3 sera levels and body temperature in two different acute inflammation models in rats 2021 (1)